Cargando…
Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease with high morbidity and mortality, especially in advanced patients. We aimed to develop multi-omics panels of biomarkers for the diagnosis and explore its molecular subtypes. METHODS: A total of 40 stable...
Autores principales: | Zhang, Zili, Wang, Jian, Li, Yuanyuan, Liu, Fei, Chen, Lingdan, He, Shunping, Lin, Fanjie, Wei, Xinguang, Fang, Yaowei, Li, Qiongqiong, Zhou, Juntuo, Lu, Wenju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007826/ https://www.ncbi.nlm.nih.gov/pubmed/36899372 http://dx.doi.org/10.1186/s12931-023-02349-x |
Ejemplares similares
-
Gene Expression Trajectories from Normal Nonsmokers to COPD Smokers and Disease Progression Discriminant Modeling in Response to Cigarette Smoking
por: Zhang, Zili, et al.
Publicado: (2022) -
Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and chronic obstructive pulmonary disease
por: Zhang, Zili, et al.
Publicado: (2022) -
Proteomic Analyses Identify Differentially Expressed Proteins and Pathways Between Low-Risk and High-Risk Subtypes of Early-Stage Lung Adenocarcinoma and Their Prognostic Impacts
por: Zhou, Juntuo, et al.
Publicado: (2021) -
Applications of liquid chromatography-mass spectrometry based metabolomics in predictive and personalized medicine
por: Zhou, Juntuo, et al.
Publicado: (2022) -
Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease
por: Zhou, Juntuo, et al.
Publicado: (2020)